Uterine cancer
MONDO:0002715Primary or metastatic malignant neoplasm involving the uterine corpus and/or the cervix.
Also known as: neoplasm of uterus, tumor of uterus, tumour of uterus, uterine tumor, uterine tumour, uterus neoplasm, cancer of the uterus, cancer of uterus
3990 clinical trials for this condition and its sub-types, 96 tagged with Uterine cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Uterine cancer
-
Cervical cancer 576 trials · 700 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- High-grade neuroendocrine carcinoma of the cervix uteri 4 trials
- Malignant neoplasm of endocervix 0 trials · 4 incl. sub-types Sub-types →
- Cervix melanoma 1 trial
- Malignant mixed epithelial and mesenchymal tumor of cervix uteri 0 trials · 1 incl. sub-types Sub-types →
- Cervical Wilms tumor 0 trials
- Malignant germ cell tumor of cervix uteri 0 trials
- Sarcoma of cervix uteri 0 trials Sub-types →
- Uterine ligament cancer 0 trials Sub-types →
-
Endometrial cancer 458 trials · 650 incl. sub-types
2 sub-types
- Endometrial carcinoma 209 trials · 316 incl. sub-types Sub-types →
- Endometrioid stromal sarcoma 2 trials Sub-types →
-
Uterine carcinoma 3 trials · 614 incl. sub-types
9 sub-types
- Cervical carcinoma 257 trials · 317 incl. sub-types Sub-types →
- Endometrial carcinoma 209 trials · 316 incl. sub-types Sub-types →
- Endometrial serous adenocarcinoma 36 trials
- Uterus carcinoma in situ 0 trials · 16 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
-
Uterine corpus cancer 33 trials · 85 incl. sub-types
12 sub-types
- Endometrial serous adenocarcinoma 36 trials
- Uterine corpus sarcoma 12 trials · 19 incl. sub-types Sub-types →
- Uterine body mixed cancer 0 trials · 14 incl. sub-types Sub-types →
- Adenoid cystic carcinoma of the corpus uteri 0 trials
- High-grade neuroendocrine carcinoma of the corpus uteri 0 trials
- Low-grade neuroendocrine tumor of the corpus uteri 0 trials
- Malignant germ cell tumor of corpus uteri 0 trials Sub-types →
- Papillary carcinoma of the corpus uteri 0 trials
- Squamous cell carcinoma of the corpus uteri 0 trials
- Transitional cell carcinoma of the corpus uteri 0 trials
- Undifferentiated carcinoma of the corpus uteri 0 trials
- Uterine corpus endometrial carcinoma 0 trials
-
Uterine carcinosarcoma 23 trials · 32 incl. sub-types
2 sub-types
- Carcinosarcoma of the corpus uteri 13 trials
- Cervical carcinosarcoma 0 trials
-
Placenta cancer 0 trials · 1 incl. sub-types
1 sub-type
- Placental choriocarcinoma 1 trial
-
Uterine adnexa cancer 0 trials
2 sub-types
- Broad ligament malignant neoplasm 0 trials Sub-types →
- Round ligament malignant neoplasm 0 trials
Most studied deeper sub-types
-
New pill targets Hard-to-Treat cancers in early human trial
Disease control Not yet recruitingThis early-phase study tests an experimental oral drug called KQB368 in 48 adults with advanced solid tumors (like lung, colorectal, or uterine cancer) that have a specific KRAS mutation (G12C or G12S). The main goals are to find a safe dose and see if the drug can shrink tumors.…
Phase 1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New needle biopsy could spare women unnecessary uterus surgery
Diagnosis Not yet recruitingThis study tests a new, less invasive biopsy method for uterine masses. The procedure uses a thin needle guided by ultrasound through the cervix to take a tissue sample. Researchers want to see if it can accurately tell benign from malignant growths, potentially helping women avo…
Sponsor: Assiut University • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Vitamins e and CoQ10 tested as shield against radiation damage
Symptom relief Not yet recruitingThis study tests whether taking high doses of vitamin E and CoQ10 daily for 90 days can reduce chronic side effects from pelvic radiation in people treated for prostate, uterine, cervical, or anal cancer. Researchers will monitor safety, side effects, and quality of life in 200 a…
Phase 1/2 • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Doctors' teamwork under the microscope: can better meetings lead to better cancer care?
Knowledge-focused Not yet recruitingThis study looks at how doctors in tumor board meetings work together when discussing ovarian and uterine cancer cases. About 400 physicians will fill out surveys after each meeting to measure things like communication, teamwork, and decision-making. The goal is to understand wha…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC
-
Could your daily urine predict uterine cancer?
Knowledge-focused Not yet recruitingThis study will ask 50 people aged 35 and older with abnormal uterine bleeding to collect daily urine samples and track their bleeding at home for several months. Researchers will use a home monitor to measure hormone levels and see if certain patterns are linked to uterine cance…
Sponsor: University of British Columbia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
HPV-Positive pelvic cancer: study probes hidden toll on sex life
Knowledge-focused Not yet recruitingThis study follows 42 women with HPV-positive pelvic cancer (cervix, vagina, vulva, or anus) to understand how radiotherapy, with or without surgery, affects their sexual quality of life. Participants complete questionnaires about sexual function and emotional distress over time.…
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood test may spot cancer recurrence months before scans
Knowledge-focused Not yet recruitingThis study is testing a new blood test that looks for tiny bits of cancer DNA (called minimal residual disease or MRD) in patients with endometrial or cervical cancer. The goal is to see if this test can find cancer coming back earlier than standard scans or exams. About 600 part…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Gene test could help young women with uterine cancer preserve fertility
Knowledge-focused Not yet recruitingThis study looks at 100 women aged 18-45 with early-stage endometrial cancer who want to preserve their fertility. Researchers will analyze the tumor's molecular subtype (based on gene testing) to see how it affects response to hormone therapy and recurrence rates. The goal is to…
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC